Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-03-05 @ 10:46 AM
Study NCT ID:
NCT02312193
Status:
COMPLETED
Last Update Posted:
2022-01-04
First Post:
2014-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects
Sponsor:
Neuromed IRCCS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LMB02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None